Home
About
Overview
Sharing Data
ORCID
Help
History (45)
Principal Investigator
Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum.
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM.
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
See All 45 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
View in:
PubMed
subject areas
Anemia
B-Cell Maturation Antigen
Humans
Immunotherapy, Adoptive
Multiple Myeloma
T-Lymphocytes
authors with profiles
Andrzej Jakubowiak